Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The main objective of this study is to determine the time interval following the last treatment dose of enoxaparin at which the amount of anti-Xa level activity is reliably less than 0.2 international unit per milliliter (IU/mL) in patients presenting for elective surgery.
Epistemonikos ID: ff1a6c03a994d2961f40ad8e1a9756475912b070
First added on: May 21, 2024